Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Medical Research|April 11, 2025
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemiaAnouar Hafiane, Annalisa Ronca, Matteo Incerti, et al.
BBA Advances|April 21, 2023
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophagesAnouar Hafiane, Alessandro Pisaturo, Annalisa Ronca, et al.
European Journal of Clinical Investigation|March 16, 2022
Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments?Qidi Ying, Annalisa Ronca, Dick C Chan, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 15, 2023
Effects of a dietary intervention with Mediterranean vs lacto-ovo vegetarian diets on HDL function: Results from the CARDIVEG studyAnnalisa Ronca, Nicoletta Pellegrini, Giuditta Pagliai, et al.
Journal of Clinical Lipidology|August 24, 2022
Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipaseLivia Pisciotta, Alice Ossoli, Annalisa Ronca, et al.
Journal of Medicinal Food|October 31, 2019
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic PatientsElena Formisano, Andrea Pasta, Anna L Cremonini, et al.
Journal of Clinical Medicine|November 27, 2019
Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell FormationSabrina Pagano, Alessandra Magenta, Marco D'Agostino, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitorsFabiana Perrone, Elda Favari, Giuseppe Maglietta, et al.
Journal of Clinical Lipidology|July 29, 2020
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)Claudia Stefanutti, Livia Pisciotta, Elda Favari, et al.
Pageof 1